CAS 959850-74-9

Fórmula: C16H18N6O4

InChI: InChI=1S/C14H14N6O2.C2H4O2/c15-14(16)18-17-9-3-5-11-6-4-10-19(11)12-7-1-2-8-13(12)20(21)22;1-2(3)4/h1-10H,(H4,15,16,18);1H3,(H,3,4)/b5-3+,17-9+;

Clave InChI: FIESOFUABUPMMH-WAJHRQJSSA-N

SMILES: CC(=O)O.C1=CC=C(C(=C1)N2C=CC=C2/C=C/C=N/N=C(N)N)[N+](=O)[O-]

AP1189 (acetate)

CAS: 959850-74-9

Ref: IN-DA01X6T4

AP1189 acetate

CAS: 959850-74-9

AP1189 acetate

Fórmula: C₁₆H₁₈N₆O₄

Pureza: ≥98%

Peso molecular: 358.35

Ref: 54-BUP07626

AP1189 acetate

CAS: 959850-74-9

AP1189 acetate is a biased agonist at melanocortin 1 and melanocortin 3 receptors.

Fórmula: C₁₆H₁₈N₆O₄

Pureza: 99.95%

Forma y color: Solid

Peso molecular: 358.35

Ref: TM-T9596

(E)-N-[Trans-3-{1-(2-nitrophenyl)-1H-pyrrol-2-yl} allylidenamino]guanidinium acetate

CAS: 959850-74-9

(E)-N-[Trans-3-{1-(2-nitrophenyl)-1H-pyrrol-2-yl} allylidenamino]guanidinium acetate is a research tool that has been shown to be an activator of a variety of receptors. It binds to the receptor, which is an ion channel protein, and alters its properties. This compound has been shown to bind to ligands and receptors by competitive inhibition. In addition, it has been shown to inhibit the binding of antibodies to cell surface antigens. This compound may have potential use in pharmacology as a therapeutic drug for neurological disorders such as Alzheimer's disease.

Fórmula: C₁₆H₁₈N₆O₄

Pureza: Min. 95%

Peso molecular: 358.35 g/mol

Ref: 3D-JNB85074